Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Brachytherapy"
DOI: 10.1016/j.brachy.2018.01.010
Abstract: PURPOSE Management of locally recurrent or persistent esophageal cancer (EC) after standard chemoradiation is challenging. This study updates our experience of treating medically inoperable EC patients with endoluminal high-dose-rate brachytherapy (EHDRBT) including the patients treated… read more here.
Keywords: esophageal cancer; locally recurrent; persistent esophageal; brachytherapy ... See more keywords